NASDAQ · Shell Companies · USD

Alpex Acquisition Corporation (ALPX) Stock Analysis

Alpex Acquisition Corporation (ALPX) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

ALPX

$9.95

+$0.01 (+0.05%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ALPX with… →

ALPX Key Statistics

As of Sep 4, 2026

Trading

Open: $9.95
Previous Close: $9.94
52-Week Range: 9.81–10.00
Volume: 4.34K

Valuation

Market Cap: $147.11M

Financials (FY)

Profit margin: 0.00%
Shares Outstanding: 11.92M

Dividend and dates

Avg Volume: 88.83K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ALPX Valuation vs Shell Companies Median

Median of 325 stocks

Metric	ALPX	Shell Companies median	vs median
Profit margin	0.00%	0.00%	0.0 pts above

Medians across 325 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The market values Alpex Acquisition Corporation (ALPX) at $147.11M. The company sits in the Financial Services sector, in the Shell Companies industry.

ALPX last closed at $9.95 on September 4, 2026. That is +$0.01 (+0.05%) against the previous close. Over the past 52 weeks the price has ranged from $9.81 to $10.00. The latest close sits 1.38% above that 52-week low.

Financial Health

The reported profit margin is 0%.

Growth & Income

No dividend is on file for ALPX.

2026 is still running; the price is +1.07% year to date.

Peer Comparison

Alpex Acquisition Corporation (ALPX) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Alpex Acquisition Corporation	ALPX	$147.11M	—
Churchill Capital Corp XI	CCXI	$746.38M	—
Churchill Capital Corp X	CCCX	$711.00M	—
Drugs Made In America Acquisition II Corp.	DMII	$647.83M	35.1

The Shell Companies industry average P/E ratio is 45.2x. Alpex Acquisition Corporation has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Shell Companies Stocks

CCXI

Churchill Capital Corp XI

$746.38M

CCCX

Churchill Capital Corp X

$711.00M

DMII

Drugs Made In America Acquisition II Corp.

$647.83M

BCSS

Bain Capital GSS Investment Corp.

$602.40M

EVAC

EQV Ventures Acquisition Corp. II

$602.01M

CXII

Churchill Capital Corp XII

$594.94M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

JPM

JPMorgan Chase & Co.

$953.33B

Visa Inc.

$700.27B

Mastercard Incorporated

$507.39B

BAC

Bank of America Corporation

$438.31B

View all Financial Services stocks →

About Alpex Acquisition Corporation

Alpex Acquisition Corporation focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2026 and is based in Wilmington, Delaware.